0001140361-14-027378.txt : 20140702
0001140361-14-027378.hdr.sgml : 20140702
20140702134051
ACCESSION NUMBER: 0001140361-14-027378
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140630
FILED AS OF DATE: 20140702
DATE AS OF CHANGE: 20140702
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OncoMed Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001302573
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 383572512
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-995-8200
MAIL ADDRESS:
STREET 1: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pollard-Knight Denise
CENTRAL INDEX KEY: 0001297000
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35993
FILM NUMBER: 14955527
MAIL ADDRESS:
STREET 1: C/O IDENIX PHARMACEUTICALS, INC.
STREET 2: 60 HAMPSHIRE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc1.xml
FORM 4
X0306
4
2014-06-30
0
0001302573
OncoMed Pharmaceuticals Inc
OMED
0001297000
Pollard-Knight Denise
C/O ONCOMED PHARMACEUTICALS, INC.
800 CHESAPEAKE DRIVE
REDWOOD CITY
CA
94063
1
0
0
0
Common Stock
2014-06-30
4
S
0
11485
23.5889
D
2043509
I
See Footnote
The shares of common stock of OMED are owned by Phase4 Ventures III LP ("Phase4"). The Reporting Person is a partner of Phase4 Partners Limited, which is the manager of Phase4. The Reporting Person disclaims beneficial ownership of the reported securities held by Phase4 except to the extent of her pecuniary interest therein.
/s/ Denise Pollard-Knight
2014-07-02